<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>American Journal of Medical Case Reports</journalTitle>
<eissn>2374-216X</eissn>
<publicationDate>2025-08-12</publicationDate>
<volume>13</volume>
<issue>7</issue>
<startPage>37</startPage>
<endPage>40</endPage>
<doi>10.12691/ajmcr-13-7-1</doi>
<publisherRecordId>AJMCR20251371</publisherRecordId>
<documentType>article</documentType>
<title language="eng">Myeloid Sarcoma with a PICALM每MLLT10 Fusion Presenting as an Isolated Mediastinal Mass in a Middle-Aged Asian Male: A Case Report</title>
<authors>
<author>
<name>Jorge L車pez Villegas</name>
<email>jlopezv@ccss.sa.cr</email>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Leonardo Granados Altamirano</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Jos谷 Rojas Rodr赤guez</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Betzab谷 Rojas Mena</name>
<affiliationId>2</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">Hematology Department, Dr. Rafael 芍ngel Calder車n Guardia Hospital, Caja Costarricense de Seguro Social, San Jos谷, Costa Rica</affiliationName>


<affiliationName affiliationId="2">1Hematology Department, Dr. Rafael 芍ngel Calder車n Guardia Hospital, Caja Costarricense de Seguro Social, San Jos谷, Costa Rica</affiliationName>
</affiliationsList>
<abstract language="eng">Myeloid sarcoma (MS), also known as granulocytic sarcoma or chloroma, is a rare extramedullary manifestation of acute myeloid leukemia (AML). Mediastinal presentation is exceedingly uncommon and may lead to misdiagnosis, particularly when hematologic parameters are preserved. We report the case of a 44-year-old male who presented with constitutional symptoms and an isolated anterior mediastinal mass without peripheral blood abnormalities. Diagnosis was established through flow cytometry, histopathology, and immunohistochemistry. Molecular profiling revealed a complex mutational landscape including PHF6, TP53, WT1 mutations, and a PICALM每MLLT10 fusion. The patient was treated with AML-directed chemotherapy and remains under close surveillance. This case highlights the diagnostic challenges and prognostic implications of extramedullary AML with rare genetic alterations.</abstract>
<fullTextUrl format="pdf">https://pubs.sciepub.com/ajmcr/13/7/1/ajmcr-13-7-1.pdf</fullTextUrl>
<keywords language="eng"><keyword>Myeloid sarcoma</keyword>
<keyword>acute myeloid leukemia</keyword>
<keyword>mediastinal mass</keyword>
<keyword>extramedullary leukemia</keyword>
</keywords>
</record>
</records>
